Peking Union Medical College Hospital

This study looked at two drug combinations to keep ovarian cancer from coming back in patients whose cancer had responded to initial treatment. The plan was to enroll 70 people, but only 5 joined before the study was stopped. Participants took either three drugs (apatinib, fluzop…

This study looked at whether adding cyclosporine to rituximab works better than rituximab alone for people with a kidney disease called idiopathic membranous nephropathy. Only 12 people took part before the study was stopped early. The goal was to see if the combination could red…

This study tested whether giving roxadustat before heart bypass surgery could prevent acute kidney injury, a common complication. The trial planned to include 98 adults aged 18-80 with planned bypass surgery. However, the study was terminated early, so the full results are not av…